All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Reported results | 2011-000901-37 | A PHASE 2, MULTICENTER, DOUBLE-BLIND, RANDOMIZED, ADJUNCTIVE PLACEBO-CONTROLLED TRIAL WITH AN OPEN-LABEL EXTENSION TO EVALUATE THE EFFICACY AND SAFETY OF YKP3089 IN SUBJECTS WITH TREATMENT RESISTANT P... | 2021-01-28 | due-trials |
Listed as ongoing, but also has a completion date and reported results | 2013-001858-10 | A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose- Response Trial of YKP3089 as Adjunctive Therapy in Subjects with Partial Onset Seizures, with Optional Open-Label Extension | 2021-04-05 | bad-data |
Listed as ongoing, but also has a completion date and reported results | 2015-001859-67 | An Open Label, Multicenter, Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects with Partial Onset Seizures | 2021-03-31 | bad-data |
Ongoing | 2018-001337-41 | A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Cenobamate Adjunctive Therapy in Subjects with Primary Generalized Tonic-Clonic Seizures | not-yet-due | |
Ongoing | 2018-002981-37 | A Multicenter Open-label Extension Study to Evaluate the Long-term Safety of Cenobamate Adjunctive Therapy in Subjects with Primary Generalized Tonic-Clonic Seizures | not-yet-due | |
Other | 2020-005344-27 | Open-Label Safety and Efficacy Study of Cenobamate (YKP3089) in Pediatric Subjects with Partial-onset (Focal) Seizures | not-yet-due | |
Other | 2022-001256-42 | A Randomized, Double-blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Carisbamate (YKP509) as Adjunctive Treatment for Seizures Associated with Lennox-Gastaut Syndrome in Chil... | not-yet-due |